The EspeRare Foundation, established by three former Merck Serono employees:Caroline Kant, Florence Porte and Béatrice Greco is the result of their determination to develop a unique operating model for the benefit of patients suffering from rare diseases, a field with high unmet needs and hardly no treatments available.
The Foundation will play a central role by pioneering a collaborative system that brings together the right stakeholders to explore the therapeutic value of existing compounds, ultimately accelerating the R&D process in rare diseases.